- In the United States, medical cannabis is legal in 31 states and the District of Columbia. Nine of these, with D.C., have also legalized cannabis for adult use. In June, Canada became the second nation to legalize an adult-use market (due to open next month).
- As states increasingly legalize cannabis and the industry grows throughout global markets, the potential for individual cannabis stocks to see an upside in prices reflects their ability to outperform.
- Year to date, cannabis companies have seen a positive run, with 7 of the top 12 cannabis stocks, by market cap, posting returns of 200% or greater.
- Shares of Canopy Growth Corp (OTCPK:TWMJF) are up more than 500% since Sept. 14, 2017, helped by direct investments from Constellation Brands. As of market close on Sept. 14, 2018, Canopy Growth Corp is the largest company in the cannabis industry, with a market cap of $10.81 billion.
- The cannabis industry is rife with opportunities for investors: An alternative to investing in high-risk penny stocks is to allocate investment resources for more established and larger companies in the industry.
- As cannabis stocks continue to rally, prudent investors should consider taking profits and exercising caution.
|
|
|
|
Watch our CannaClip below to see what the report covers!
|
|
|
|
CBD Report Cannaclip
|
|
Q: How long until cannabis gets commoditized, and would that need federal legalization? Can it happen with only a limited number of legal states?
Commoditization of cannabis prices is already occurring in pockets of legal U.S. states. Adjacent legal states are experiencing a direct correlation between prices in the legal and illegal markets. The movement of products across state lines, though the illicit market, drives price normalization and hence, a commoditized market... Read our full answer here
|
|
|
Ask Our Experts is a new weekly interactive feature in the CannaBit.
|
|
|
By J. J. McCoy, Senior Managing Editor, New Frontier Data
|
|
|
Even before word of the DEA’s landmark rescheduling of cannabidiol (CBD) for GW Pharmaceutical’s FDA-approved Epidiolex, the cannabis market has had a hot summer...
|
|
Country and Company profiles
We have an ever-expanding list of country and company profiles:
- Country profiles from new global coverage across Europe, Latin America, Africa and APAC
- US and Canada public companies profiled
- Risk indicators
- Easy to digest
- Free with an Essential Subscription
|
|
|
The number of marijuana-friendly states in America is steadily growing, with Canada becoming the second country to fully legalise cannabis. Considering the local developments that have made the personal use of marijuana legal, it may be time to start investigating the profitability of a cannabis company, like these celebrities did.
Read the full article here >
|
|
|
|
Governor Signs Marijuana Legalization Bill, Making History In US Territory
|
|
New State Hemp Programs: Growing Hemp In Wisconsin, Vermont, Oregon & Nevada
|
|
|
It’s high times for soaring marijuana stocks on Wall Street
|
|
1 In 6 Teens Who Use Cannabis Will Become Addicted - Study
|
|
|
|
|
|
|
|
